Fibrinolytic changes in a patient with toxic shock syndrome release of active u-PA

Intensive Care Medicine

Volumn 24, Issue 3, 1998, Pages 258-261

  Haj, M A ^a   Robbie, L A ^a   Croll, A ^a   Adey, G D ^b   Bennett, B ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NHS GRAMPIAN   (United Kingdom)

Author keywords

Acute renal failure; Acute respiratory distress syndrome; Plasminogen activator inhibitor 1; Tissue type plasminogen activator; Toxic shock syndrome; Urokinase type plasminogen activator

Indexed keywords

ALPHA 2 ANTIPLASMIN; FIBRINOGEN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; ENDOMETRIUM ABLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; INTENSIVE CARE; POLYACRYLAMIDE GEL ELECTROPHORESIS; STAPHYLOCOCCUS; SYMPTOM; TOXIC SHOCK SYNDROME;

ADULT; BACTEREMIA; CATHETER ABLATION; CROSS INFECTION; FEMALE; FIBRINOGEN; FIBRINOLYSIS; HUMANS; MULTIPLE ORGAN FAILURE; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTOPERATIVE COMPLICATIONS; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031919131     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050561     Document Type: Article

References (10)

1. McWilliam NA, Robbie LA, Barelle CJ, Adey GD, Prasad S, Bennett B, Booth NA (1996) Evidence for an active fibrinolytic system in normal human bone marrow. Br J Haematol 93: 170-176
2. 2macroglobulin and C I inhibitor. Studies on patients with defibrination and a fibrinolytic state after electroshock or complicated labor. Blood 75: 671-676
3. Williams GR (1990) The toxic shock syndrome. BMJ 300: 960
4. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP (1981) A new staphylococcal enterotoxin, F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet 1: 1017-1021
5. Pintucci G, lacoviello L, Amore C, Evangelista V, Cerletti C, Donati (1992) Cathepsin G, a polymorphonuclear cell protease. affects the fibrinolytic system by releasing PAI-1 from endothelial cells and platelets. Ann NY Acad Sci 667: 286-288
6. Haj MA, Robbie LA, Adey GD. Bennett B (1995) Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients. Thromb Haemost 74: 1528-1532
7. Sprengers ED, Princen HMG, Kooistra T, Van Hinsbergh VWM (1985) The inhibition of plasminogen activators by human hepatocytes and hepatoma cell line Hp G 92. J Lab Clin Med 105: 751-758
8. Pralong G, Calandra T, Glauser MP, Schellekens J, Verhoef J, Bachmann F, Kruithof EKO (1989) Plasminogen activator inhibitor 1: a new prognosticmarker in septic shock. Thromb Haemost 61: 459-469
9. Philippe J, Offner F, Declerck PJ, Leroux-Roels G. Vogelaers D, Baele G, Collen D (1991) Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thromb Haemost 65: 291-299
10. Philippe J, Doojewaard G, Offner F, Turion P, Baele G, Leroux-Roels G (1992) Granulocyte elastase. tumour necrosis factor alpha and urokinase levels as prognostic markers in severe infection. Thromb Haemost 68: 19-23